The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

NCT01081834 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

678

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Canagliflozin
DRUG: Placebo
DRUG: Sitagliptin

Sponsor

Janssen Research & Development, LLC